Accelerate Diagnostics Announces 1-for-10 Reverse Stock Split
4.6 (147) · € 32.00 · Auf Lager
/PRNewswire/ -- Accelerate Diagnostics, Inc., (NASDAQ: AXDX) (the "Company") a leading provider of innovative rapid diagnostic solutions, announced that it
Accelerate Diagnostics Inc. to undergo 1-for-10 reverse stock split - Phoenix Business Journal
Lucid Diagnostics Readies $75 Million IPO (Pending:LUCD)
T2 Biosystems Announces Reverse Stock Split Effective Today
Affinity-Switchable Interaction of Biotin and Streptavidin for the Signal-ON Detection of Small Molecules
424B4
Accelerate Diagnostics Announces 1-for-10 Reverse Stock Split
Share Market Highlights 13 December 2023: Sensex, Nifty end marginally higher; IT stocks drag - The Hindu BusinessLine
Quotient to effect reverse stock split, regain Nasdaq compliance
Electronics June-1 2023 - Browse Articles
A New survey of the Needham Question
Breast cancer test results 'outstanding
PAVmed Provides Business Update and Third Quarter Financial Results
G Medical Innovations Holdings Ltd.
Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results -October 31, 2023 at 09:51 am EDT
